TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CURAD CLINICAL CARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

CURAD CLINICAL CARE

ST13

US500000087689477

Class

5

Filing

87689477

Registration

6449079

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

02/20/2025

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

11/17/2017

Registration date

08/10/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/10/2021

Last transaction

02/20/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/08/2019

First use in commerce

02/08/2019

Drawing code

3

Owner type

13

Owner location

NORTHFIELD, IL

Examiner

KAJUBI, ELIZABETH

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word mark "CURAD" in stylized lettering within a design of a shield and a second, smaller shield design featuring a highly stylized caduceus symbol appears at the bottom portion. Both the word "CURAD" and the caduceus design are in white, both shield designs contain exterior border elements as well as interior border elements. The interior of the larger shield is green and the exterior and interior border elements are green and silver. The interior of the smaller shield design is blue and the exterior border is silver. The words "CLINICAL CARE" in stylized font in black appear below the design.

Holders and representatives

Holders

MEDLINE INDUSTRIES, LP
Medline Industries, Inc.

Representatives

Janet A. Marvel Pattishall, McAuliffe, Newbury, Hilliard & Geralds

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Adhesive bandages; medical dressings and absorbent pads for skin wounds; hydrogel pads

Publications

History of USPTO decisions and trademark events.

46 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/20/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/20/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/10/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/08/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/07/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/19/2021

IUAF

USE AMENDMENT FILED

06/17/2021

EISU

TEAS STATEMENT OF USE RECEIVED

06/17/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/08/2020

EX5G

SOU EXTENSION 5 GRANTED

12/07/2020

EXT5

SOU EXTENSION 5 FILED

12/04/2020

EEXT

SOU TEAS EXTENSION RECEIVED

12/04/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/27/2020

EX4G

SOU EXTENSION 4 GRANTED

06/26/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/26/2020

EXT4

SOU EXTENSION 4 FILED

06/11/2020

EEXT

SOU TEAS EXTENSION RECEIVED

06/11/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/10/2019

EX3G

SOU EXTENSION 3 GRANTED

12/06/2019

EXT3

SOU EXTENSION 3 FILED

12/06/2019

EEXT

SOU TEAS EXTENSION RECEIVED

12/06/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/07/2019

EX2G

SOU EXTENSION 2 GRANTED

06/05/2019

EXT2

SOU EXTENSION 2 FILED

06/05/2019

EEXT

SOU TEAS EXTENSION RECEIVED

06/05/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/09/2018

EX1G

SOU EXTENSION 1 GRANTED

11/07/2018

EXT1

SOU EXTENSION 1 FILED

11/07/2018

EEXT

SOU TEAS EXTENSION RECEIVED

11/07/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/19/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/24/2018

PUBO

PUBLISHED FOR OPPOSITION

04/24/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/04/2018

ALIE

ASSIGNED TO LIE

03/18/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/13/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

03/13/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/13/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

03/13/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/13/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/28/2018

GNRT

NON-FINAL ACTION E-MAILED

02/28/2018

CNRT

NON-FINAL ACTION WRITTEN

02/28/2018

DOCK

ASSIGNED TO EXAMINER

02/22/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/01/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/30/2017

NWAP

NEW APPLICATION ENTERED

11/21/2017

Continuous trademark protection

Get notified about every new filing that threatens CURAD CLINICAL CARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.